CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

Lark

Lark Health is the leading virtual chronic disease management and prevention platform. Lark helps people stay healthy and in control of their conditions, such as Diabetes, Prediabetes, Cardiovascular Disease, and Anxiety from the comfort of their homes.

San Jose Behavioral Health Hospital

San Jose Behavioral Health is an inpatient psychiatric hospital that provides comprehensive treatment services for adults and adolescents struggling with mental health or behavioral health issues in the Silicon Valley area and surrounding communities.

OneSpaWorld

Worldwide provider and innovator in the fields of wellness, beauty, rejuvenation and transformation across the globe at sea on cruise ships and on land.

Fremont Area Medical Center

Fremont Area Medical Center is a Fremont, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SaluGenecists Inc

SaluGenecists Inc is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.